331 related articles for article (PubMed ID: 17205041)
1. Characterization of beta-ketoadipate pathway from multi-drug resistance bacterium, Acinetobacter baumannii DU202 by proteomic approach.
Park SH; Kim JW; Yun SH; Leem SH; Kahng HY; Kim SI
J Microbiol; 2006 Dec; 44(6):632-40. PubMed ID: 17205041
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new catechol branch of the beta-ketoadipate pathway induced for benzoate degradation in Acinetobacter lwoffii K24.
Yoon YH; Yun SH; Park SH; Seol SY; Leem SH; Kim SI
Biochem Biophys Res Commun; 2007 Aug; 360(3):513-9. PubMed ID: 17610839
[TBL] [Abstract][Full Text] [Related]
3. Analysis of aromatic catabolic pathways in Pseudomonas putida KT 2440 using a combined proteomic approach: 2-DE/MS and cleavable isotope-coded affinity tag analysis.
Kim YH; Cho K; Yun SH; Kim JY; Kwon KH; Yoo JS; Kim SI
Proteomics; 2006 Feb; 6(4):1301-18. PubMed ID: 16470664
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202.
Lee SY; Yun SH; Lee YG; Choi CW; Leem SH; Park EC; Kim GH; Lee JC; Kim SI
J Antimicrob Chemother; 2014 Jun; 69(6):1483-91. PubMed ID: 24486871
[TBL] [Abstract][Full Text] [Related]
5. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the benzoate degradation pathway in Acinetobacter sp. KS-1.
Kim SI; Song SY; Kim KW; Ho EM; Oh KH
Res Microbiol; 2003 Dec; 154(10):697-703. PubMed ID: 14643408
[TBL] [Abstract][Full Text] [Related]
7. Repression of 4-hydroxybenzoate transport and degradation by benzoate: a new layer of regulatory control in the Pseudomonas putida beta-ketoadipate pathway.
Nichols NN; Harwood CS
J Bacteriol; 1995 Dec; 177(24):7033-40. PubMed ID: 8522507
[TBL] [Abstract][Full Text] [Related]
8. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii.
Shi WF; Jiang JP; Mi ZH
Chin Med J (Engl); 2005 Jan; 118(2):141-5. PubMed ID: 15667800
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii.
Yun SH; Choi CW; Kwon SO; Park GW; Cho K; Kwon KH; Kim JY; Yoo JS; Lee JC; Choi JS; Kim S; Kim SI
J Proteome Res; 2011 Feb; 10(2):459-69. PubMed ID: 21053951
[TBL] [Abstract][Full Text] [Related]
10. Identification of an OprD homologue in Acinetobacter baumannii.
Dupont M; Pagès JM; Lafitte D; Siroy A; Bollet C
J Proteome Res; 2005; 4(6):2386-90. PubMed ID: 16335991
[TBL] [Abstract][Full Text] [Related]
11. The ß-ketoadipate pathway of Acinetobacter baumannii is involved in complement resistance and affects resistance against aromatic antibiotics.
Breisch J; Huber LS; Kraiczy P; Hubloher J; Averhoff B
Environ Microbiol Rep; 2022 Feb; 14(1):170-178. PubMed ID: 35023294
[TBL] [Abstract][Full Text] [Related]
12. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii.
Martí S; Sánchez-Céspedes J; Oliveira E; Bellido D; Giralt E; Vila J
Proteomics; 2006 Apr; 6 Suppl 1():S82-7. PubMed ID: 16544276
[TBL] [Abstract][Full Text] [Related]
14. Media containing aromatic compounds induce peculiar proteins in Acinetobacter radioresistens, as revealed by proteome analysis.
Giuffrida MG; Pessione E; Mazzoli R; Dellavalle G; Barello C; Conti A; Giunta C
Electrophoresis; 2001 May; 22(9):1705-11. PubMed ID: 11425226
[TBL] [Abstract][Full Text] [Related]
15. Degradation of aromatic compounds by Acinetobacter radioresistens S13: growth characteristics on single substrates and mixtures.
Mazzoli R; Pessione E; Giuffrida MG; Fattori P; Barello C; Giunta C; Lindley ND
Arch Microbiol; 2007 Jul; 188(1):55-68. PubMed ID: 17483933
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and functional characterization of the genes encoding benzoate and p-hydroxybenzoate degradation by the halophilic Chromohalobacter sp. strain HS-2.
Kim D; Kim SW; Choi KY; Lee JS; Kim E
FEMS Microbiol Lett; 2008 Mar; 280(2):235-41. PubMed ID: 18248426
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals.
Cho YJ; Moon DC; Jin JS; Choi CH; Lee YC; Lee JC
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):185-90. PubMed ID: 19361944
[TBL] [Abstract][Full Text] [Related]
18. Peptide mass fingerprinting- and 2-DE/MS-based analysis of the biodegradation potential for monocyclic aromatic hydrocarbons in Pseudomonas sp.
Kim SI; Park SH; Kim JW; Leem SH; Shin DJ; Kim SH; Lee DH; Kahng HY
Biotechnol Lett; 2007 Oct; 29(10):1475-81. PubMed ID: 17636390
[TBL] [Abstract][Full Text] [Related]
19. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Lin L; Ling BD; Li XZ
Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612
[TBL] [Abstract][Full Text] [Related]
20. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
